The Enactment and Implementation of Korea's Digital Medical Products Act: A Comparative Study Exploring Policy Implications.

BACKGROUND

With the rapid expansion of the digital healthcare industry, advanced medical technologies, including artificial intelligence-based diagnostic software and digital therapeutics, are being introduced at an unprecedented pace. However, existing regulatory frameworks have encountered substantial challenges in adequately addressing the unique characteristics of these products. In response, Republic of Korea (South Korea) has enacted the world's first "Digital Medical Products Act" and established an integrated regulatory system tailored to this emerging domain.

METHODS

This study undertook a comparative analysis across three regulatory dimensions-scope of application, approval procedures, and reimbursement policies-by examining corresponding legal frameworks in the United States, Germany, the United Kingdom, and Japan. In addition, qualitative interviews were conducted with three experts, each possessing more than 10 years of experience in digital healthcare regulation, to capture early field-level perspectives and identify areas that require refinement.

RESULTS

The findings demonstrated a generally positive assessment of the institutional significance of the new system, while also highlighting several limitations, including the absence of detailed evaluation criteria and the potential for confusion among stakeholders in practical implementation.

CONCLUSION

Based on these results, this study provides policy implications to guide the future advancement and refinement of regulatory frameworks for digital medical products.